Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-20

Clinical Trial Update: Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on gadoxetate-enhanced imaging for detecting prostate cancer; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • gadoxetate (gadoxetate disodium)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-03-20